Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

R&D Systems™ Recombinant Cynomolgus Siglec-2/CD22 Fc Chimera Protein

Catalog No. 10031SL050
Change view
Click to view available options
Quantity:
50 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
10-031-SL050 50 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Catalog No. 10-031-SL050 Supplier R&D Systems™ Supplier No. 10031SL050
Add to Cart
Add to Cart
This item is not returnable. View return policy

The Recombinant Cynomolgus Siglec-2/CD22 Fc Chimera Protein is derived from HEK293

  • Siglecs are sialic acid specific I-type lectins that are characterized by an extracellular domain (ECD) with an N-terminal Ig-like V-type domain followed by varying numbers of Ig-like C2-type domains.
  • Siglec-2, also known as B cell antigen CD22 or B-lymphocyte cell adhesion molecule (BL-CAM), is a B cell restricted glycoprotein that is expressed in the cytoplasm of progenitor B and pre-B cells and on the surface of mature B cells.
  • In humans, two distinct Siglec-2 cDNAs that arise from differential RNA processing of the same gene have been isolated.
  • Within the ECD, cynomolgus Siglec-2 shares 84%, 55%, and 56% aa sequence identity with human, mouse, and rat Siglec-2, respectively.
  • Siglec-2 is an adhesion molecule that preferentially binds alpha 2,6- linked sialic acid on the same (cis) or adjacent (trans) cells.
  • Consistent with a single ligand-binding region, the first two N-terminal Ig-like domains mediated CD22 adhesion with lymphocytes, neutrophils, monocytes, and erythrocytes.
  • Besides its role as an adhesion molecule, Siglec-2 is a co-receptor that physically interacts with B cell receptor (BCR) and is rapidly phosphorylated upon BCR ligation.
  • It negatively regulates BCR signals by recruiting tyrosine phosphatase SHP-1 to its ITIMs.
  • Phosphorylated Siglec-2 can also interact with other intracellular effector proteins such as Syk, PLC gamma, PI3 kinase and Grb-2, suggesting it may play a role in positive signaling.

Specifications

Accession Number EHH59463
For Use With (Application) Bioactivity
Gene ID (Entrez) 933
Molecular Weight (g/mol) 102 kDa
Purification Method >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining
Quantity 50 μg
Source

Human embryonic kidney cell, HEK293-derived cynomolgus monkey Siglec-2/CD22 protein

Cynomolgus Monkey Siglec-2/CD22 (Asp20-Arg687) Accession # EHH59463IEGRMDHuman IgG1 (Pro100-Lys330)N-terminus C-terminus

Storage Requirements Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 3 months, ≤ -20°C under sterile conditions after reconstitution.
Endotoxin Concentration <0.10 EU per 1 μg of the protein by the LAL method
Conjugate Unconjugated
Reconstitution Reconstitute at 250 μg/mL in PBS
Buffer Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.